A new vaccine is out just in time for fall, offering protection against the latest variant. Anyone 6 months and older can get ...

Moderna 's (NASDAQ: MRNA) stock fell by 13% on Sept. 12 upon the announcement of extensive cost cuts that would affect a ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

With all these shots, some Canadians may have questions about the benefit of each vaccine, whether they should get every shot and how often to get them, and if it's safe to get them all at once or if ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

Health experts and scientists around the world are sharing thoughts on what they believe will be the next dominant COVID ...

The VDH reported on May 22 that a second juvenile in the "Under 10" age range has died of COVID-19 since the pandemic began ...

A new COVID variant is raising questions and capturing the attention of researchers heading into the fall and winter season.

Moderna stock tumbled again Friday on a series of downgrades and price-target cuts following a "tough update" at its R&D Day.